TransCode Therapeutics, Inc. Common Stock

RNAZ XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

Short interest (May 15)

4.0%

Net Short (Jun 03 ): 4.7%

Borrow Fee

15.80%

↓ 14.9%

Available Shares

20K

↑ 7.0%

Price Chart

Company Overview

TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001829635

Asset Type: CS

Market Data

Market Cap: $5,022,346

Employees: 12

Status: Active

Short Interest

Current Borrow Fee 15.80%

Range: 15.80% - 16.93%

Available Shares 20K

Range: 1K - 40K

Recent Changes

Fee Change: ↓ 4.4%

Available Change: ↓ 26.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime